Calendario›MDWD›Long Term Follow up of Scars Formation and Quality of Life Assessment Study
Long Term Follow up of Scars Formation and Quality of Life Assessment Study
Ensayo de MediWound Ltd. en Scars Formation · Quality of Life (del registro, en inglés).
- Fase
- no aplica
- Estado
- Completado
- Participantes
- 148
- Centros
- 1
- Fin del objetivo primario
- nov 2011
previstos
fecha real
Qué significa cada fase y cada estado.
Estudio observacional. Comenzó en jun 2011.
Qué mide
1. Scar assessment of target wounds that have been treated by Debrase or SOC during MW2004-11-02 using Modified Vancouver Scar Scale (MVSS) (Approximately 2 years after wound closure) (del registro, en inglés)
Cómo lo describe el promotor
En el documentoEn inglés, del registroIn previous study (MW2004-011-02), patients with burn wounds had their damaged skin removed by either standard of care treatment or by Debrase Gel Dressing (DGD), which is composed of enzymes that dissolve the damaged skin selectively (DGD removes only the damaged skin and not other parts of the skin). The burn wound, like any other wound, heals by the formation of scar at the injured site in order to replace the destroyed tissues. Scarring is not a static process, but rather a dynamic one, changing over time, especially during the first 24 months post-injury. Scars and patients' quality of life from two treatment arms (DGD and SOC) will be compared in order to evaluate the long term influence of damaged skin removal and wound care techniques on scar formation and maturation.
Más ensayos de MDWD
| Ensayo | Fase | Estado | Lectura de resultados |
|---|---|---|---|
| EscharEx 5% | Fase 1/2 | Reclutando pacientes | may 2022 (prevista, ya pasada: sin actualizar en el registro) |
| EscharEx · VALUE | Fase 3 | Reclutando pacientes | dic 2026 (prevista) |
| EscharEx · VLU | Fase 2 | Aún sin reclutar | dic 2027 (prevista) |
| EX-03 | Fase 2 | Aún sin reclutar | ago 2028 (prevista) |
| EscharEx | Fase 2 | Completado | may 2022 (real) |
| EscharEx | Fase 2 | Completado | dic 2021 (real) |
Todos los de MDWD, en su ficha.
Ficha completa en ClinicalTrials.gov (NCT01350700), actualizada en oct 2017.